Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05665920

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Clinical Trial to Assess the Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Instituto Brasileiro de Controle do Cancer · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The reduction in the number of fractions in radiotherapy is especially attractive in several senses, and even more so considering breast cancer, which has a high incidence and generally favorable prognosis. Thus, as a reference Institution, the investigators intend to start the treatment of selected patients with a radiotherapy scheme of 26 Gy / 5 fractions in one week, in a controlled manner, through this project.The investigators consider the moment extremely propitious to start the study, as in addition to having the first publication of a large randomized study, proving the effectiveness and safety of the strategy, the investigators will be able to benefit more patients and the health system itself by minimizing the daily visits of these patients at the hospital.

Detailed description

This is a prospective, interventional, exploratory, controlled, randomized study in a 1:1 ratio, to be carried out in a single center, and seeks to evaluate the safety and efficacy of hypofractionated irradiation in women with breast cancer who receive nodal irradiation regional.

Conditions

Interventions

TypeNameDescription
RADIATIONUltra-hypofractionated whole breast radiotherapyUltra-hypofractionated whole breast radiotherapy, 26 Gray (26Gy) in 5 fractions for one week
RADIATIONStandard RadiationStandard Radiation: Whole Breast Irradiation, at 40 Gy, in 15 fractions and drainage

Timeline

Start date
2022-10-18
Primary completion
2027-10-18
Completion
2030-12-31
First posted
2022-12-27
Last updated
2022-12-29

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT05665920. Inclusion in this directory is not an endorsement.